Nutrigenomic Company to Present Unique Business Model
SAN DIEGO, Oct. 9 /PRNewswire/ -- Salugen, Inc., a personalized health and wellness company and recent consecutive year award winner from the Natural Products Association for its nutritional genetic research, announces today that it has been selected to present at the first annual Nutrition Capital Network investor meeting, October 17, 2007 in San Francisco, CA.
Presenting companies are pre-screened by the Nutrition Capital Network institutional investors for their uniqueness and protectibility of their product or service; strength of business model; experience of the management team and the caliber of the investment proposal. Investors attending this meeting include: The Dannon Company, DuPont, Nestle, PHYSIC Ventures, Rosewood Capital, North Castle Partners, Sherbrooke Capital, Burrill & Co, and many others.
Salugen CEO Brian Meshkin states, "We are honored to present Salugen's unique business to the investment community attending the Nutrition Capital Network inaugural meeting. Salugen's technology has been scientifically and clinically validated by our extensive compilation of peer-reviewed publications, years of research, record of clinical studies, and extensive intellectual property that sets us apart from other companies involved in nutrigenomics. We look forward to the opportunity of sharing our vision with strategic investor partners at the meeting."
Salugen currently markets DNA-customized nutritional solutions under three brands, GenoTrim(TM) for weight management (http://www.GenoTrim.com), SpaGen (TM) for optimal health and wellness (http://www.SpaGen.com) and Haveos(TM) for substance abuse attenuation.
Salugen, Inc., a leading personalized health and wellness company,
engages in the discovery, development and commercialization of
|SOURCE Salugen, Inc.|
Copyright©2007 PR Newswire.
All rights reserved